Baglivo, S.; Bianconi, F.; Metro, G.; Gili, A.; Tofanetti, F.R.; Bellezza, G.; Ricciuti, B.; Mandarano, M.; Teti, V.; Siggillino, A.;
et al. Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy. Genes 2021, 12, 992.
https://doi.org/10.3390/genes12070992
AMA Style
Baglivo S, Bianconi F, Metro G, Gili A, Tofanetti FR, Bellezza G, Ricciuti B, Mandarano M, Teti V, Siggillino A,
et al. Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy. Genes. 2021; 12(7):992.
https://doi.org/10.3390/genes12070992
Chicago/Turabian Style
Baglivo, Sara, Fortunato Bianconi, Giulio Metro, Alessio Gili, Francesca Romana Tofanetti, Guido Bellezza, Biagio Ricciuti, Martina Mandarano, Valeria Teti, Annamaria Siggillino,
and et al. 2021. "Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy" Genes 12, no. 7: 992.
https://doi.org/10.3390/genes12070992
APA Style
Baglivo, S., Bianconi, F., Metro, G., Gili, A., Tofanetti, F. R., Bellezza, G., Ricciuti, B., Mandarano, M., Teti, V., Siggillino, A., Reda, M. S., Chiari, R., Pistola, L., Sidoni, A., Minotti, V., Roila, F., & Ludovini, V.
(2021). Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy. Genes, 12(7), 992.
https://doi.org/10.3390/genes12070992